Insomnia News and Research

Latest Insomnia News and Research

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

PuraMed BioScience, Inc., a researcher, developer, and marketer of over-the-counter medicinal and healthcare products, announced the results of clinical trials that found its over-the-counter migraine medication product, LipiGesic M, has "robust efficacy".

22 May 2013

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder.

20 May 2013

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22.

20 May 2013

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PLMS in patients with idiopathic moderate-to-severe Restless Legs Syndrome/Willis-Ekbom disease.

18 May 2013

New study finds association between sleep duration and suicide risk in insomnia

A new study found a relationship between sleep duration and suicidal thoughts in people with insomnia.

16 May 2013

Routine depression screening for adults not recommended in primary care settings

For adults with no apparent symptoms of depression, routine screening is not recommended in primary care settings because of the lack of high-quality evidence on the benefits and harms of screening for depression, according to new evidence-based guidelines from the Canadian Task Force on Preventive Health Care published in CMAJ.

14 May 2013

Study says insomnia may be an indicator of future hospitalization among middle-aged and older adults

Having trouble falling or staying asleep? According to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health, insomnia may be an important indicator of future hospitalization among middle-aged and older adults.

13 May 2013

Insomnia and altered sleep duration may increase risk of CHD and CVD during menopause

Insomnia and other sleep disturbances are common among perimenopausal and postmenopausal women and may increase their risk of coronary heart disease (CHD) and cardiovascular disease (CVD).

10 May 2013

Addressing sleep hygiene prior to CPAP initiation may help improve adherence

A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea.

8 May 2013

Study shows association between diet, sleepiness and alertness

A new study suggests that your level of sleepiness or alertness during the day may be related to the type of food that you eat.

8 May 2013

Restless legs syndrome and insomnia: a possible explanation

Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication.

7 May 2013

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

A new report shows that the number of emergency department visits involving adverse reactions to the sleep medication zolpidem rose nearly 220 percent from 6,111 visits in 2005 to 19,487 visits in 2010.

2 May 2013

Cognitive training improves insomnia sleep quality

Older adults with insomnia could benefit from computerized cognitive training, which researchers have found helps in the initiation and maintenance of sleep.

30 Apr 2013

Hostility linked to poor sleep quality

People with high levels of hostility are like to have poor sleep quality, suggests research showing a robust link between the two features.

29 Apr 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

24 Apr 2013

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

24 Apr 2013

New data on Enanta's lead HCV protease inhibitor to be presented at International Liver Congress

Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.

23 Apr 2013

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

23 Apr 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Afghanistan's geography is dominated by a collection of craggy peaks, the highest-a mountain known as Noshaq-has been measured to 7,492 meters. Consequently, the soldiers on duty in this mountainous terrain must often ascend to great heights as part of their duty.

22 Apr 2013

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics, Inc. today announced that a proof-of-concept trial found dalfampridine extended release tablets, marketed as AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, improved walking in people with post-stroke deficits.

16 Apr 2013

Insomnia News and Research

Latest Insomnia News and Research

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

New study finds association between sleep duration and suicide risk in insomnia

Routine depression screening for adults not recommended in primary care settings

Study says insomnia may be an indicator of future hospitalization among middle-aged and older adults

Insomnia and altered sleep duration may increase risk of CHD and CVD during menopause

Addressing sleep hygiene prior to CPAP initiation may help improve adherence

Study shows association between diet, sleepiness and alertness

Restless legs syndrome and insomnia: a possible explanation

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

Cognitive training improves insomnia sleep quality

Hostility linked to poor sleep quality

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

New data on Enanta's lead HCV protease inhibitor to be presented at International Liver Congress

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Insomnia News and Research

Latest Insomnia News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in